HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas
Angela Sosin(The Barbara Ann Karmanos Cancer Institute), Ayad Al‐Katib(Wayne State University)
Cited by 37
Related Papers
SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status
|Journal of Hematology & Oncology|2009|32